Navigating Headwinds: BASF's Restructuring Progress Meets a Murky Forecast

BASF's 2026 forecast shows high uncertainty. 2025 earnings missed target despite one-time gains. Restructuring saves €1.7B, but currency headwinds persist.

The outlook presented by BASF for 2026 is defined not by precision, but by a wide range of potential outcomes. This broad guidance underscores the significant challenges in forecasting, as the chemical giant contends with a sluggish economy, adverse currency movements, and U.S. tariff policies. The central question is whether the company's ongoing transformation and cost-cutting initiatives can effectively counter these persistent pressures.

Financial Performance: Operational Weakness Offset by One-Time Gains

In the 2025 fiscal year, BASF's revenue declined by nearly three percent to approximately €59.7 billion. While sales volumes saw a slight increase, this progress was erased by lower selling prices and negative currency translation effects.

The operational picture was more clearly reflected in earnings. Adjusted EBITDA fell by 9.5% to just under €6.6 billion, landing below the company's own target range of €6.7 to €7.1 billion. Despite this, net income attributable to shareholders rose from €1.3 billion to €1.6 billion. This bottom-line increase was driven by special items, including a gain from the sale of the construction coatings business to Sherwin-Williams and payments from the German government related to state guarantees for former Russia activities of the Wintershall DEA subsidiary.

Recent market sentiment has been cautious. Shares closed at €48.55 on Friday, marking a daily decline of 2.22%. However, they show a 30-day gain of 5.50% and are up 8.52% since the start of the year.

A 2026 Outlook Marred by Currency Risks and Uncertainty

For the current year, BASF anticipates adjusted EBITDA, before special items, to land between €6.2 billion and €7.0 billion. The sheer width of this forecast band highlights the prevailing uncertainty. CEO Markus Kamieth tempered expectations, noting that the company does not foresee a significant market recovery or a clear geopolitical easing in the near term.

A specific and immediate headwind is the weakness of the U.S. dollar. BASF stated that the dollar's performance alone could reduce operating earnings by up to €200 million in the first quarter. Furthermore, volume development in January was weak across most regions, with the exception of China.

Performance across business segments is expected to be mixed. The Nutrition & Care and Chemicals segments are projected to deliver significantly higher earnings, while Industrial Solutions expects a slight increase. The Materials and Agricultural Solutions segments are likely to see a slight decline, primarily due to currency effects. BASF is targeting a free cash flow of €1.5 to €2.3 billion for 2026, compared to €1.3 billion in 2025.

Tangible Progress in Restructuring and Financial Discipline

Amid the operational challenges, BASF's restructuring program is delivering measurable results. The company achieved annual cost savings of approximately €1.7 billion by the end of 2025—€100 million above the initial plan. The savings target for the end of 2026 has now been raised to €2.3 billion, up from a previous goal of €2.1 billion. Concurrently, management positions were reduced by 11% between December 2023 and December 2025, and the total workforce decreased by around 4,800 (excluding approximately 1,000 new hires at the new integrated site in China).

Capital return remains a clear priority. A dividend of €2.25 per share is proposed again for 2025. Additionally, BASF has accelerated a share buyback program. Between November 2025 and the end of June 2026, the company plans to repurchase shares worth up to €1.5 billion. This forms part of a larger, announced program totaling at least €4 billion by the end of 2028.

The balance sheet is also strengthening, with net debt declining to €18.3 billion at the end of 2025. CFO Dirk Elvermann announced that a substantial portion of the proceeds from portfolio measures in 2026 will be used to further reinforce the financial position. The company also received about €900 million from state guarantees in 2025, with a further €800 million expected in the first half of 2026.

The Annual Shareholders' Meeting is scheduled for April 30, 2026, where a vote will also be held on the election of Mark Garrett as a new member of the Supervisory Board.

In summary, BASF's situation presents a dual narrative. Operationally, the company missed its own target in 2025, yet it is demonstrating tangible progress in its restructuring, free cash flow outlook, and balance sheet health. The wide EBITDA forecast for 2026, however, serves as a stark reminder of how heavily broader economic conditions, currency volatility, and trade policy continue to weigh on planning.